The Food and Drug Administration provides less stringent oversight of overseas research trials used in deciding whether to approve a drug than those conducted domestically. That was the finding of my recent study, published in the Journal of Clinical Pharmacology. My study highlighted loopholes in the agency’s oversight processes that exploited vulnerable people and led More
The post The FDA’s Lax Oversight of Research in Developing Countries can do Harm to Vulnerable Participants appeared first on CounterPunch.org.
This content originally appeared on CounterPunch.org and was authored by C. Michael White.
C. Michael White | Radio Free (2021-11-16T09:19:29+00:00) The FDA’s Lax Oversight of Research in Developing Countries can do Harm to Vulnerable Participants. Retrieved from https://www.radiofree.org/2021/11/16/the-fdas-lax-oversight-of-research-in-developing-countries-can-do-harm-to-vulnerable-participants/
Please log in to upload a file.
There are no updates yet.
Click the Upload button above to add an update.